Tuberculosis (TB)

In Focus: Global strategy to end cryptococcal meningitis in people living with HIV

Cryptococcal meningitis is the second biggest killer of people living with HIV after tuberculosis (TB). Now, a global initiative, the Ending Cryptococcal Meningitis Deaths by 2030 Strategic Framework aims to get the gold standard drug to treat the disease – flucytosine – registered in countries that need it. By Amy Green for Spotlight and Health-e News.
Read More » In Focus: Global strategy to end cryptococcal meningitis in people living with HIV

Op-ed: Global Covid-19 vaccine race shows why South Africa must prioritise our own research and development

Faced with inadequate access to essential treatments, South Africa must prioritise health research and development. The COVID-19 pandemic has shown how poor and marginalised South Africans are affected by international factors, and so it is essential to include communities in advocating for better homegrown research and development, writes community activist Ntando Yola.
Read More » Op-ed: Global Covid-19 vaccine race shows why South Africa must prioritise our own research and development

Newsletter Subscription